96917 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Proteoglycans, e.g. aggreccan
PRODUCTION OF RECOMBINANT LUBRICIN
#2PROTEOGLYCAN PRODUCTION METHOD AND PROTEOGLYCAN
#3ANTI-FIBROUS CELLS, MEDICAMENT COMPRISING THE CELLS, AND METHOD FOR OBTAINING THESE CELLS
#4POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME
#5MULTIFUNCTIONAL PROTEIN MOLECULES COMPRISING DECORIN AND USE THEREOF
#6Dual-Mode Pharmaceutical Composition for Peptide-Specific Targeted Positron Emission Tomography and Boron Neutron Capture Therapy and the Use Thereof
#7Helper-dependent adenoviral gene therapy delivery and expression system
#8POLYPEPTIDES BINDING SELECTIVELY HEPARIN OR HEPARAN SULFATE GLYCOSAMINOGLYCANS AND CELL-PENETRATING POLYPEPTIDES COMPRISING THE SAME
#9METHOD OF INDUCING CARDIOMYOCYTES PROLIFERATION AND TREATING HEART DISEASES
#10AGRIN POLYPEPTIDE AND USES THEREOF
#11METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTION
#12Wound Healing Composition and Uses Thereof
#13PRODUCTION OF RECOMBINANT LUBRICIN
#14HOMING PEPTIDE-GUIDED DECORIN CONJUGATES FOR USE IN TREATING EPIDERMOLYSIS BULLOSA
#15GPC3 CAR- T CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#16PURIFICATION OF RECOMBINANTLY PRODUCED POLYPEPTIDES
#17BIOACTIVE AGENTS AND METHODS RELATED THERETO
#18Multifunctional protein molecules comprising decorin and use thereof
#19Recombinant lubricins, and compositions and methods for using the same
#20High affinity monoclonal antibodies targeting glypican-1 and methods of use
#21DECORIN COMPOSITIONS AND USE THEREOF
#22ANTI-GPC3 CHIMERIC ANTIGEN RECEPTORS (CARs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF
#23OCULAR HYDROGEL COMPOSITIONS
#24Methods and compositions for treating and preventing viral infection
#25COMPOSITIONS AND METHODS FOR TREATING CORNEAL ENDOTHELIUM
#26Ligand controling interaction between gags with their effector molecules and use thereof
#27Polypeptides capable of producing glucans having alpha (1-->2) linkages and use of the same
#28HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE
#29Production of recombinant lubricin
#30Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
#31Recombinant versican isoforms and related compositions and methods
#32Tumor marker, and method for collecting and detecting tumor cell in distinction from contaminant cell
#33Carbohydrate tethering at cell surfaces to induce immune response
#34Method of inducing cardiomyocytes proliferation and treating heart diseases
#35Multifunctional protein molecules comprising decorin and use thereof
#36Chemoenzymatic glycoengineering of antibodies and FC fragments thereof
#37HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE
#38Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)
#39Recombinant lubricin
#40Peptides of syndecan-1 for inhibiting angiogenesis
#41PURIFIED BIGLYCAN VARIANTS AND METHODS OF USE THEREOF
#42BIGLYCAN VARIANT POLYPEPTIDES AND METHODS OF USE
#43D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS
#44EXTRACELLULAR MATRIX-BINDING SYNTHETIC PEPTIDOGLYCANS
#45Nucleic acid molecules encoding for chimeric CSPG4 proteins and therapeutic uses thereof
#46BIGLYCAN MUTANTS AND RELATED THERAPEUTICS AND METHODS OF USE
#47Selectin and ICAM/VCAM peptide ligand conjugates
#48Method of inducing cardiomyocytes proliferation and treating heart diseases
#49Polypeptides capable of producing glucans having alpha-1,2 branches and use of the same
#50Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
#51Application and uses of PRG4 and therapeutic modulation thereof
#52Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
#53Method for production of heparin and heparan sulfate
#54D-amino acid derivative-modified peptidoglycan and methods of use thereof
#55GPC3 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#56Neocartilage compositions and methods for modifying proteoglycan content
#57Collagen-binding synthetic peptidoglycans, preparation, and methods of use
#58Versikine for inducing and potentiating an immune response
#59Peptides of syndecan-1 for inhibiting angiogenesis
#60D-amino acid derivative-modified peptidoglycan and methods of use thereof
#61Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin
#62FIBROMODULIN PEPTIDE
#63Recombinant lubricin composition
#64Diagnosis and treatment of autoimmune diseases
#65Method for removing genomically unstable IPS cells and synthetic peptide used therefor
#66Control of rheological properties of mixed hyaluronate/lubricin solutions
#67Collagen-binding synthetic peptidoglycans, preparation, and methods of use
#68Extracellular matrix-binding synthetic peptidoglycans
#69Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
#70Biochemical markers for CVD risk assessment
#71Genes and proteins associated with angiogenesis and uses thereof
#72Methods for increasing N-glycan occupancy and reducing production of hybrid N-glycans in pichia pastoris strains lacking ALG3 expression
#73Use of fibromodulin and lumican for increasing muscle mass
#74Veterinary decorin compositions and use thereof
#75Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
#76Extracellular matrix-binding synthetic peptidoglycans
#77Biglycan variant polypeptides and methods of use
#78D-amino acid derivative-modified peptidoglycan and methods of use thereof
#79Method for mass preparation of proteoglycan
#80Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
#81Peptides of syndecan-1 for inhibit angiogenesis
#82Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
#83Genes and proteins associated with angiogenesis and uses thereof
#84SILK FIBROIN-DECORIN SCAFFOLDS
#85MODULATION OF IMMUNE RESPONSE BY NON-PEPTIDE BINDING STRESS RESPONSE POLYPEPTIDES
#86DECORIN COMPOSITIONS AND USE THEREOF
#87Fibromodulin peptide
#88Application and uses of PRG4 and therapeutic modulation thereof
#89Plants having enhanced yield-related traits and a method for making the same
#90Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
#91Biglycan mutants and related therapeutics and methods of use
#92VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION
#93THE USE OF A NON-GLYCANATED POLYPEPTIDE FOR TREATING A CANCER
#94NOVEL PROTEIN CAPABLE OF BINDING TO HYALURONIC ACID, AND METHOD FOR MEASUREMENT OF HYALURONIC ACID USING THE SAME
#95SYNDECAN-4 IS A REGULATOR OF RAC1-GTP
#96THERAPEUTIC COMPOUNDS AND METHODS
#97Protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
#98Collagen-binding synthetic peptidoglycans, preparation, and methods of use
#99VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION
#100Process for producing proteoglycan
#101Methods for promoting elastogenesis and elastin fiber formation by increasing tropoelastin expression
#102Treatment of stroke using domain V of perlecan
#103HPV antigen fusion protein vaccine compositions and uses thereof
#104Compositions and methods for purifying calreticulin
#105Methods of using LRR superfamily genes and proteins
#106ACOUSTICALLY DELIVERING METHODS AND COMPOSITONS FOR REMOTE TREATMENT OF A TUMOR
#107Perlecan fragments as biomarkers of bone stromal lysis
#108PEYER'S PATCH AND/OR M-CELL TARGETING LIGANDS
#109Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
#110Bioactive peptide for cell adhesion
#111Compositions and method for enhancing proteoglycan production
#112Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
#113Vasostatin as marrow protectant
#114Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
#115Cell compositions useful for cell-based FRET assays for clostridial toxins
#116Methods for stabilizing corneal tissue
#117Bone/joint disease sensitivity gene and use thereof
#118METHOD FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION
#119Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
#120Peptides of Syndecan-1 For Inhibiting Angiogenesis
#121Genes and proteins associated with angiogenesis and uses thereof
#122Tie-2 driven overexpression of calreticulin as an inducer of non-small cell carcinoma of lung
#123CELL-BASED FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) ASSAYS FOR CLOSTRIDIAL TOXINS
#124Decorin proteoglycan inhibitor of fibrinogen blood clotting
#125Endocan compositions and methods for the treatment of neoplasms
#126Peyer's patch and/or M-cell targeting ligands
#127Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth
#128Amino acid modified polypeptides
#129Transgenically produced decorin
#130Construction and use of synthetic constructs encoding syndecan
#131Molecular vaccine linking an endoplasmic chaperone polypeptide to an antigen
#132Decorin proteoglycan inhibitor of fibrinogen blood clotting
#133Novel polypeptides and polynucleotides encoding same